Ezallor Sprinkle | Rosuvastatin Capsule while Breastfeeding
Most health expert recommend six month of exclusive breastfeeding but statics suggest that numbers are not good, almost 95% mothers start breastfeeding but this number drops to 40% in first three month and further it drops to 15% till fifth month. Sometime its due to need of medication usage. Because of these statics its important to provide good information on safety of drugs in breastfeeding so that it can be improved when possible. In this FAQ sheet we will discuss about exposure to Ezallor Sprinkle | Rosuvastatin Capsule while breastfeeding. We will also discuss about common side effects and warnings associated with Ezallor Sprinkle | Rosuvastatin Capsule.

What is Ezallor Sprinkle | Rosuvastatin Capsule used for?


Pediatric use information for patients 7 to 17 years of age is approved for AstraZeneca’s CRESTOR (rosuvastatin calcium) tablets. However, due to AstraZeneca’s marketing exclusivity rights, this drug product is not labeled with that pediatric information. EZALLOR Sprinkle is an HMG Co-A reductase inhibitor indicated for: adult patients with hypertriglyceridemia as an adjunct to diet (1.1) adult patients with primary dysbetalipoproteinemia (Type III hyperlipoproteinemia) as an adjunct to diet (1.2) adult patients with homozygous familial hypercholesterolemia (HoFH) to reduce LDL-C, total-C, and ApoB (1.3) Limitations of use (1.4): EZALLOR Sprinkle has not been studied in Fredrickson Type I and V dyslipidemias 1.1 Hypertriglyceridemia EZALLOR Sprinkle is indicated as adjunctive therapy to diet for the treatment of adult patients with hypertriglyceridemia. 1.2 Primary Dysbetalipoproteinemia (Type III Hyperlipoproteinemia) EZALLOR Sprinkle is indicated as an adjunct to diet for the treatment of adult patients with primary dysbetalipoproteinemia (Type III Hyperlipoproteinemia). 1.3 Adult Patients with Homozygous Familial Hypercholesterolemia EZALLOR Sprinkle is indicated as adjunctive therapy to other lipid-lowering treatments (e.g., LDL apheresis) or alone if such treatments are unavailable to reduce LDL-C, Total-C, and ApoB in adult patients with homozygous familial hypercholesterolemia. 1.4 Limitations of Use EZALLOR Sprinkle has not been studied in Fredrickson Type I and V dyslipidemias.

What are the risk associated with Ezallor Sprinkle | Rosuvastatin Capsule usage while breastfeeding? What precautions shall I take while using it in breastfeeding?

Ezallor Sprinkle | Rosuvastatin Capsule high risk while breastfeeding
As Ezallor Sprinkle | Rosuvastatin Capsule is made of only Rosuvastatin, and Rosuvastatin is unsafe to use in breastfeeding we can safely reach on conclusion that Ezallor Sprinkle | Rosuvastatin Capsule is also unsafe to use while breastfeeding. Below is detailed analysis of Rosuvastatin and Ezallor Sprinkle | Rosuvastatin Capsule during location. We recommend you to go through provided detailed analysis as below take decision accordingly. We also recommend you talk to your health care provider before making final decision.

Ezallor Sprinkle | Rosuvastatin Capsule Breastfeeding Analsys


Rosuvastatin while Breastfeeding

Unsafe

CAS Number: 147098-20-2

Statin pharmacologically acts by inhibiting cholesterol synthesis. Excretion into breast milk is non-significant. Its low oral biodisponibility makes absorption by the infant unlikely. Influence on alteration of breast milk fat composition is unknown. High amount of cholesterol is required by the infant to ensure appropriate development of nervous system, cell membranes and hormones or vitamin production. Avoiding use while exclusive breastfeeding would be advisable. Atorvastatin is probably safer because of a higher molecular weight that would interfer with excretion into breast milk. Pravastatin has also shown a low excretion. Simvastatin has the lowest oral biodisponibility. Interruption of drug hypercholesterolemia treatment while breastfeeding would probably not affect long-term outcome of the disease. A hypolipidemic diet should be followed.

Ezallor Sprinkle | Rosuvastatin Capsule Breastfeeding Analsys - 2


Rosuvastatin while Breastfeeding

CAS Number: 287714-41-4

Ezallor Sprinkle | Rosuvastatin Capsule and breastfeeding

Levels of rosuvastatin in milk are low, but no relevant published information exists with its use during breastfeeding. The consensus opinion is that women taking a statin should not breastfeed because of a concern with disruption of infant lipid metabolism. However, others have argued that children homozygous for familial hypercholesterolemia are treated with statins beginning at 1 year of age, that statins have low oral bioavailability, and risks to the breastfed infant are low, especially with rosuvastatin and pravastatin.[1] Until more data become available, an alternate drug may be preferred, especially while nursing a newborn or preterm infant.

Is Ezallor Sprinkle | Rosuvastatin Capsule safe while breastfeeding

What should I do if already breastfed my kid after using Ezallor Sprinkle | Rosuvastatin Capsule?

We have already established that Ezallor Sprinkle | Rosuvastatin Capsule is unsafe in breastfeeding and breastfeeding while using Ezallor Sprinkle | Rosuvastatin Capsule is not a good idea however if have already used and then breastfed the baby then you shall monitor the behavior and health of baby closely and inform your doctor as soon as possible. In case of emergency please call 911.


I am nursing mother and my doctor has suggested me to use Ezallor Sprinkle | Rosuvastatin Capsule, is it safe?

If your doctor knows that you are breastfeeding mother and still prescribes Ezallor Sprinkle | Rosuvastatin Capsule then there must be good reason for that as Ezallor Sprinkle | Rosuvastatin Capsule is considered unsafe, It usually happens when doctor finds that overall advantage of taking outweighs the overall risk.


If I am using Ezallor Sprinkle | Rosuvastatin Capsule, will my baby need extra monitoring?

Yes, Extra monitoring is required if mother is using Ezallor Sprinkle | Rosuvastatin Capsule and breastfeeding as it is considered unsafe for baby.


Who can I talk to if I have questions about usage of Ezallor Sprinkle | Rosuvastatin Capsule in breastfeeding?

US
National Womens Health and Breastfeeding Helpline: 800-994-9662 (TDD 888-220-5446) 9 a.m. and 6 p.m. ET, Monday through Friday

UK
National Breastfeeding Helpline: 0300-100-0212 9.30am to 9.30pm, daily
Association of Breastfeeding Mothers: 0300-330-5453
La Leche League: 0345-120-2918
The Breastfeeding Network supporter line in Bengali and Sylheti: 0300-456-2421
National Childbirth Trust (NCT): 0300-330-0700

Australia
National Breastfeeding Helpline: 1800-686-268 24 hours a day, 7 days a week

Canada
Telehealth Ontario for breastfeeding: 1-866-797-0000 24 hours a day, 7 days a week